Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and SK Biopharmaceuticals, a Korean-based company leads the way in biotech innovation with groundbreaking drug research, development, and commercialization worldwide, announced a research and development collaboration at the BIO 2026 International Convention to discover AI-enabled innovative drug candidates in the neuroimmune area of the central nervous system (CNS).

Scientists built a flying robot that is both easy to control and energy-efficient, especially in changing wind conditions. The robot can change its shape and uses wind to stay in the air, instead of relying on thrust-generating motors. The idea is inspired by how birds fly which remain naturally stable when airborne. The work was published in npj Robotics on June 21, 2026.

Digging deep into the molecular mechanisms behind ALS, researchers at the Les Turner ALS Center at Northwestern Medicine have discovered why nerve cells overfire in the disease. Not only that—they have also designed a new drug to stop this overfiring, which could potentially slow or stop the disease from progressing.

Harnessing the power of generative AI, researchers at Tsinghua University have developed AIGP—a diffusion-based generative framework that enables instant translation of optical properties into fabrication-ready metasurfaces. By using transmission, phase, and polarization as “prompts,” AIGP directly maps optical properties to subwavelength, fabricable structures, generating high-fidelity metasurface designs in seconds. This breakthrough overcomes critical bottlenecks in photonic inverse design and paves the way for large-scale, AI-driven generative optical devices.